We are live on ! Find out more
EMR

Errol M. Rudman Portfolio holdings

AUM $148M
1-Year Est. Return 19.65%
This Fund
S&P 500
This Quarter Est. Return
+4.31%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$19.3M
Cap. Flow
+$16.2M
Cap. Flow %
13.03%
Top 10 Hldgs %
78.15%
Holding
27
New
8
Increased
4
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$2.92M
2
GLD icon
SPDR Gold Trust
GLD
+$2.55M
3
CNC icon
Centene
CNC
+$2.01M
4
UAL icon
United Airlines
UAL
+$1.92M
5
EXPE icon
Expedia Group
EXPE
+$1.7M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$666K
2
CCRN icon
Cross Country Healthcare
CCRN
+$564K
3
IBB icon
iShares Biotechnology ETF
IBB
+$515K
4
CVS icon
CVS Health
CVS
+$415K
5
TDG icon
TransDigm Group
TDG
+$410K

Sector Composition

Rank Sector Weight
1 Industrials 49.4%
2 Healthcare 26.85%
3 Consumer Discretionary 7.07%
4 Technology 2.98%
5 Financials 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDG icon
1
TransDigm Group
TDG
$67.7B
$24.2M 19.51%
83,665
-1,462
-2% -$410K
LVLT
2
DELISTED
Level 3 Communications Inc
LVLT
$16.1M 13%
347,417
+20,000
+6% +$1.01M
UAL icon
3
United Airlines
UAL
$38.2B
$12.7M 10.26%
242,400
+40,000
+20% +$1.92M
DAL icon
4
Delta Air Lines
DAL
$55.5B
$8.21M 6.63%
208,710
– –
MHK icon
5
Mohawk Industries
MHK
$6.61B
$7.01M 5.66%
35,000
– –
CVS icon
6
CVS Health
CVS
$137B
$6.44M 5.19%
72,354
-4,400
-6% -$415K
GLD icon
7
SPDR Gold Trust
GLD
$129B
$6.28M 5.07%
50,000
+20,000
+67% +$2.55M
HCA icon
8
HCA Healthcare
HCA
$82.4B
$5.61M 4.53%
74,200
-8,700
-10% -$666K
ESRX
9
DELISTED
Express Scripts Holding Company
ESRX
$5.59M 4.51%
79,226
– –
CNC icon
10
Centene
CNC
$32.9B
$4.7M 3.79%
140,400
+57,800
+70% +$2.01M
CBPO
11
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$4.61M 3.72%
37,001
– –
XRAY icon
12
Dentsply Sirona
XRAY
$2.75B
$3.46M 2.79%
58,248
– –
HUM icon
13
Humana
HUM
$48.2B
$2.97M 2.4%
+16,800
New +$2.92M
ST icon
14
Sensata Technologies
ST
$6.54B
$2.25M 1.82%
58,160
– –
CCRN icon
15
Cross Country Healthcare
CCRN
$428M
$2M 1.61%
169,638
-42,800
-20% -$564K
EXPE icon
16
Expedia Group
EXPE
$31.8B
$1.75M 1.41%
+15,000
New +$1.7M
TMO icon
17
Thermo Fisher Scientific
TMO
$197B
$1.5M 1.21%
9,400
– –
CCMP
18
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.44M 1.16%
+27,118
New +$1.33M
LAZ icon
19
Lazard
LAZ
$4.17B
$1.01M 0.82%
27,911
– –
CSII
20
DELISTED
Cardiovascular Systems, Inc.
CSII
$712K 0.57%
+30,000
New +$657K
SF
21
Stifel
SF
$11.9B
$558K 0.45%
32,625
– –
QHC
22
DELISTED
Quorum Health Corporation
QHC
$477K 0.38%
+76,091
New +$624K
ARA
23
DELISTED
American Renal Associates Holdings, Inc
ARA
$413K 0.33%
+22,597
New +$510K
THC icon
24
Tenet Healthcare
THC
$16.9B
$267K 0.22%
11,800
-8,600
-42% -$224K
AMN icon
25
AMN Healthcare
AMN
$1.32B
$265K 0.21%
+8,300
New +$315K
1
2

Similar funds

HAM
Hillswick Asset Management Stamford, Connecticut $150M AUM 7.89% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RMPT
Raytheon Master Pension Trust Waltham, Massachusetts $140M AUM 5.65% 1-Year Est. Return
QAM
Quantres Asset Management Cayman, Cayman Islands $138M AUM 11.79% 1-Year Est. Return
CWM
Catamount Wealth Management Westport, Connecticut $176M AUM 15.01% 1-Year Est. Return
RCA
Restructuring Capital Associates Stamford, Connecticut $115M AUM 20.18% 1-Year Est. Return
CI
Caerus Investors New York $183M AUM 0.18% 1-Year Est. Return
LS
Lattice Strategies Wayne, Pennsylvania $109M AUM 3.52% 1-Year Est. Return

Errol M. Rudman's Q3 2016 Portfolio in Review

As of Q3 2016, Errol M. Rudman held 27 positions worth $124M, up 18% from $105M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Errol M. Rudman deployed $16.2M of net new capital in Q3 2016, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Humana: 16,800 shares worth $2.97M.

By sector, the portfolio is most concentrated in Industrials at 49% of assets, down from 53% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was HCA Healthcare, an estimated $666K trimmed.

  • Errol M. Rudman's largest Q3 2016 buy was Humana: 16,800 shares worth $2.97M.
  • Errol M. Rudman added most to SPDR Gold Trust in Q3 2016, an estimated $2.55M increase.
  • Errol M. Rudman's biggest Q3 2016 reduction was HCA Healthcare, cutting an estimated $666K.
  • Errol M. Rudman fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $515K.
  • Errol M. Rudman's ten largest holdings make up 78% of its $124M portfolio in Q3 2016.
  • Errol M. Rudman opened 8 new positions and closed 1 in Q3 2016.
  • Errol M. Rudman's portfolio value rose 18% quarter-over-quarter to $124M.

Based on Errol M. Rudman's 13F filing for Q3 2016, filed 14 Nov 2016.